Effects of Hyperbaric Oxygen Preconditioning on Doxorubicin Cardiorespiratory Toxicity is a research paper published in Antioxidants (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
the National Institute of Health (NIH)
Grant: R01 HL153140
the National Institute of Health (NIH)
Grant: R01 HL144858
the National Institute of Health (NIH)
Grant: R01 HL146443
the National Institute of Health (NIH)
Grant: T32 HD043730
NIH HHS
Grant: HD043730
National Institutes of Health
Grant: 5T32HD043730-19
Interdisciplinary Training in Neuromuscular Plasticity and Rehabilitation
National Institutes of Health
Grant: 5R01HL153140-02
Hyperbaric oxygen therapy mitigates respiratoryneuromuscular pathology after spinal cord injury
National Institutes of Health
Grant: 5R01HL144858-03
Doxorubicin cardiotoxicity and the protective effects of exercise
National Institutes of Health
Grant: 5R01HL146443-05
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise
FWCI
0.92
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals